Swire Pacific Limited, a UK-based diversified corporation, has participated in a $25m B round for UK-based Green Biologics, an industrial biotechnology company. The round was led by venture capital firm Sofinnova Partners, with involvement from Capricorn Venture Partners, Oxford Capital Partners, Morningside Ventures and ConvergInce Holdings.
Chief executive of Green Biologics, Sean Sutcliffe, said: “As well as bringing exceptional skills and experience from our new investors to accelerate the development of the company, this investment round underlines the strength of Green Biologics’ commercial and technical position, and will allow us to execute our plan to bring on stream our first commercial production facility in the U.S. in 2016.”
Green Biologics is also set to acquire the assets of Central MN Ethanol Co-op, an ethanol production company following approval of a purchasing agreement in November.